Champions Oncology, Inc. - Common Stock (CSBR)
6.1000
+0.00 (0.00%)
NASDAQ· Last Trade: Jul 21st, 6:48 PM EDT

Champions Oncology (CSBR) Earnings Transcript
Via The Motley Fool · March 13, 2026
Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Misschartmill.com
Via Chartmill · March 12, 2026

This SaaS provider enables brands to personalize customer engagement across digital channels using data-driven orchestration tools.
Via The Motley Fool · February 20, 2026

This marketing technology provider delivers data-driven automation and consumer insights to enterprise clients across multiple channels.
Via The Motley Fool · February 20, 2026
Via Benzinga · September 12, 2025

Kodiak AI, Inc. delivers AI-powered navigation software for trucking, defense, and industrial fleets using proprietary sensor technology.
Via The Motley Fool · February 20, 2026

Sprinklr delivers a unified platform for enterprise customer experience management, serving global brands with integrated digital solutions.
Via The Motley Fool · February 20, 2026
Champions Oncology (CSBR) Earnings Call Transcript
Via The Motley Fool · January 7, 2026
Champions Oncology (CSBR) Earnings Transcript
Via The Motley Fool · January 7, 2026
Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins.
Via Chartmill · December 15, 2025
Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform.
Via Chartmill · September 15, 2025
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.
Via Benzinga · September 3, 2025

Via Benzinga · January 28, 2025

Via Benzinga · January 17, 2025

Via Benzinga · September 12, 2024

Via Benzinga · September 12, 2024

CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
Via InvestorPlace · July 18, 2024



